Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists …

AC Wolff, MEH Hammond, DG Hicks… - … of Pathology and …, 2014 - meridian.allenpress.com
Purpose.—To update the American Society of Clinical Oncology (ASCO)/College of
American Pathologists (CAP) guideline recommendations for human epidermal growth …

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast …

AC Wolff, MEH Hammond… - … of pathology & …, 2007 - meridian.allenpress.com
Purpose.—To develop a guideline to improve the accuracy of human epidermal growth
factor receptor 2 (HER2) testing in invasive breast cancer and its utility as a predictive …

Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline …

AC Wolff, MEH Hammond, KH Allison… - … of pathology & …, 2018 - meridian.allenpress.com
Purpose.—To update key recommendations of the American Society of Clinical Oncology
(ASCO)/College of American Pathologists (CAP) human epidermal growth factor receptor 2 …

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research …

AV Moorman, CJ Harrison, GAN Buck, SM Richards… - Blood, 2007 - ashpublications.org
Pretreatment cytogenetics is a known predictor of outcome in hematologic malignancies.
However, its usefulness in adult acute lymphoblastic leukemia (ALL) is generally limited to …

Preanalytics and precision pathology: pathology practices to ensure molecular integrity of cancer patient biospecimens for precision medicine

CC Compton, JA Robb… - … of pathology & …, 2019 - meridian.allenpress.com
Biospecimens acquired during routine medical practice are the primary sources of molecular
information about patients and their diseases that underlies precision medicine and …

Genetic Heterogeneity in HER2 Testing in Breast Cancer: Panel Summary and Guidelines

GH Vance, TS Barry, KJ Bloom… - … of pathology & …, 2009 - meridian.allenpress.com
Context.—Intratumoral heterogeneity of HER2 gene amplification has been well
documented and represents subclonal diversity within the tumor. The reported incidence of …

Improvements in cytogenetic slide preparation: controlled chromosome spreading, chemical aging and gradual denaturing

O Henegariu, NA Heerema… - … : The Journal of the …, 2001 - Wiley Online Library
Background Metaphase spreading is an essential technique for clinical and molecular
cytogenetics. Results of classical banding techniques as well as complex fluorescent in situ …

Update on late relapse of germ cell tumor: a clinical and molecular analysis

DW George, RS Foster, RA Hromas… - Journal of clinical …, 2003 - ascopubs.org
Purpose: Analysis of patients with late relapse (LR) of germ cell tumor (GCT) with reports on
clinical characteristics, outcomes, and molecular and cytogenetic features. Patients and …

Characterization of neo-centromeres in marker chromosomes lacking detectable alpha-satellite DNA

TW Depinet, JL Zackowski… - Human molecular …, 1997 - academic.oup.com
Recent studies have implicated α-satellite DNA as an integral part of the centromere,
important for the normal segregation of human chromosomes. To explore the relationship …

Distal 13q deletion syndrome and the VACTERL association: case report, literature review, and possible implications

LE Walsh, GH Vance… - American journal of …, 2001 - Wiley Online Library
We present a case of a child with del (13)(q31. 1qter), VACTERL association, and
penoscrotal transposition. Deletion of the distal long arm of chromosome 13 is associated …